Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06987890 · ClinicalTrials.gov registry record · NA

Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy

A NA study of Lung Cancer (NSCLC) and Geriatric Assessment, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT06987890: Recruiting NA study of Lung Cancer (NSCLC) and Geriatric Assessment, sponsored by Brigham and Women's Hospital.

NCT06987890 is a NA study of Lung Cancer (NSCLC) and Geriatric Assessment that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 64 participants, below the 206-participant average among 7 other Lung Cancer (NSCLC) trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06987890, a NA study of Lung Cancer (NSCLC) and Geriatric Assessment, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

National guidelines recommend that older adults with cancer undergo a special health assessment before starting cancer treatment. This type of assessment evaluates physical function, nutrition, social support, psychological well-being, medical conditions (both cancer-related and non-cancer-related), and cognitive function. The results can help doctors make better treatment decisions and determine whether additional support services-such as nutrition counseling, physical therapy, or social work-would be beneficial. Even though these assessments are recommended, they are not typically used because they need to be performed by a specialist and can take over an hour to complete. Given these challenges, a 10-15-minute assessment called the Practical Geriatric Assessment (PGA) was recently developed. The PGA can be completed by any healthcare provider and helps identify older adults who may need extra support alongside their cancer treatment. While the PGA has the potential to make geriatric assessments more accessible, the investigators do not yet know whether patients will find it useful or easy to complete. Additionally, it is unclear whether using the PGA will lead to more referrals for recommended supportive care services. This study aims to address these questions. The investigators will evaluate whether using the PGA impacts the number of patients referred to recommended supportive care services. Investigators will also evaluate how participants feel about completing the PGA, including how easy or difficult it is, and to assess the feasibility of implementing this survey on a larger scale. Finally, the investigators will use facial photographs and audio-visual data from the PGA to develop and evaluate artificial intelligence algorithm(s) to identify vulnerable patients who might benefit from additional supportive care services; namely, FaceAge, a validated deep learning model capable of estimating biological age from still facial images.

Primary Outcome

The primary endpoint for this study will be rate of referral to recommended supportive care services as compared to reported rates in historical cohorts, one month after PGA intervention.

Interventions

  • OTHER Practical Geriatric Assessment

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2025-05-26
Est. Completion 2026-06-26
Phase NA
Brigham and Women's Hospital

937 total trials

What NCT06987890 shows while recruiting

NCT06987890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 206-participant average among 7 other Lung Cancer (NSCLC) trials with a reported enrollment target (69% lower).

The record links to 3 conditions, with Lung Cancer (NSCLC) appearing as the primary indexed condition, and to 1 intervention - of which Practical Geriatric Assessment is the first listed.

NCT06987890 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06987890 about?

NCT06987890 is a clinical study titled "Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy". National guidelines recommend that older adults with cancer undergo a special health assessment before starting cancer treatment. This type of assessment evaluates physical function, nutrition, social support, psychological well-being, medical conditions (both cancer-related and non-cancer-related),...

What is the current status of trial NCT06987890?

This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-05-26. Estimated completion is 2026-06-26.

What conditions does trial NCT06987890 study?

This clinical trial studies the following conditions: Lung Cancer (NSCLC), Geriatric Assessment, Stereotactic Body Radiation Therapy (SBRT).

What interventions are being tested in trial NCT06987890?

The interventions under investigation include: Practical Geriatric Assessment (OTHER).

Who is sponsoring clinical trial NCT06987890?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06987890 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer (NSCLC)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06987890, the US trial registry maintained by the National Library of Medicine. NCT06987890 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.